Cellectis S.A. SEC filings CLLS
Cellectis S.A. has 534 filings in SEC EDGAR's recent list, going back to Dec 19, 2014. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 11, 2025 | — |
| CORRESP | Letter to the SEC | Jul 9, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2025 | — |
| EFFECT | Filing | Jan 23, 2025 | — |
| CORRESP | Letter to the SEC | Jan 21, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2025 | — |
| EFFECT | Filing | Jul 7, 2022 | — |
| CORRESP | Letter to the SEC | Jul 5, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2022 | — |
| POSASR | Filing | Jun 24, 2022 | — |
| CT ORDER | Filing | Dec 29, 2020 | — |
| CT ORDER | Filing | Apr 5, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2017 | — |
| CORRESP | Letter to the SEC | Nov 14, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2017 | — |
| CORRESP | Letter to the SEC | Oct 10, 2017 | — |
| CORRESP | Letter to the SEC | Sep 25, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2017 | — |
| EFFECT | Filing | Apr 19, 2017 | — |
| CORRESP | Letter to the SEC | Apr 14, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2017 | — |
| RW | Filing | Mar 31, 2017 | — |
| CT ORDER | Filing | May 24, 2016 | — |
| CT ORDER | Filing | Apr 2, 2015 | — |
| EFFECT | Filing | Mar 24, 2015 | — |
| EFFECT | Filing | Mar 24, 2015 | — |
| CERTNAS | Auto-generated paper document | Mar 24, 2015 | — |
| CORRESP | Letter to the SEC | Mar 23, 2015 | — |
| 8-A12B | Filing | Mar 23, 2015 | — |
| DRS/A | Filing | Feb 12, 2015 | — |
| DRSLTR | Filing | Feb 12, 2015 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2015 | — |
| DRSLTR | Filing | Jan 27, 2015 | — |
| DRS/A | Filing | Jan 27, 2015 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2015 | — |
| DRS | Filing | Dec 19, 2014 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CLLS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Paris, Lle-De-France
- SEC filer status
- Accelerated filer
- SEC CIK
- 1627281
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.